By IDSE News Staff
The Department of Health and Human Services said it would increase the supply of oseltamivir (Tamiflu, Genentech) because of increased demand. As of Dec. 10, influenza activity in the United States remains high, according to the CDC.
Twenty-five percent of laboratory samples are testing positive for flu, and almost 7% of visits to a healthcare provider were for a flu-like illness, the CDC said.
To increase supply, the agency will tap the Strategic National Stockpile (SNS).